Innovation

An Introduction to Lateral Flow and Product Development (Veterinary and Agriculture)

An Introduction to Lateral Flow and Product Development (Veterinary and Agriculture)

A Lateral Flow Immunoassay (LFIA), also known as an immunochromatographic test strip, is a rapid, simple paper based diagnostic test platform used to detect…

Why Menstrual Blood Deserves a Second Look

Why Menstrual Blood Deserves a Second Look

Rethinking What We Throw Away There exists a biological resource so rich in proteins and stem cells it could unlock earlier diagnoses for conditions…

5 Key Moments to Leverage Contract Research in Diagnostic Development

5 Key Moments to Leverage Contract Research in Diagnostic Development 

Delivering a lateral flow diagnostic test to market is a huge challenge. By leveraging contract research organisations (CRO) with expertise in development we can…

From Lab to Field: Progress in Crimean-Congo Haemorrhagic Fever Testing

From Lab to Field: Progress in Crimean-Congo Haemorrhagic Fever Testing

In the ongoing fight against Crimean-Congo Haemorrhagic Fever (CCHF), Global Access Diagnostics (GADx) has joined forces with the Liverpool School of Tropical Medicine and…

GADx Awarded Grand Prize for Maternal Health Innovation

GADx Awarded Grand Prize for Maternal Health Innovation

Global Access Diagnostics (GADx) is thrilled to announce that we have been awarded the grand cash prize for our at-home urinary tract infection diagnostic…

Rapid Diagnostics for a Better World – POCT Leipzig Insights

Rapid Diagnostics for a Better World – POCT Leipzig Insights 

Dr. Kevin Land, the Head of Innovative Research and Development at Global Access Diagnostics (GADx), delivered a compelling keynote at the prestigious POCT Leipzig…

GADx Contributes to TB Diagnostic Advancements

GADx Contributes to TB Diagnostic Advancements 

GADx is pleased to announce its significant contribution to a groundbreaking study published in PLoS One. The research, titled “Performance of Novel Antibodies for…

GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis

GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT)…

COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use

COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use

Mologic Inc., the US subsidiary of  Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced…

Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa

Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa

The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project…